CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
CME's 62% net margin towers over Morningstar's 15.3%, but valuation metrics tell a different story for 2026 investors.
In the realm of financial stocks, investors find themselves torn between CME Group (CME) and Morningstar (MORN). Both companies play pivotal roles in the infrastructure of modern finance, but their business models and market positions differ significantly.
CME Group is the world's leading derivatives marketplace. It facilitates trading in futures and options contracts on a wide array of assets. The company's latest annual report for the fiscal year 2025 revealed that 85% of its trading volume originated from its exchange members, which include major global banks and professional trading firms. In a recent strategic move, CME launched a partnership with Flutter Entertainment, a subsidiary of Flutter Entertainment, to explore the realm of prediction markets.
On the other hand, Morningstar operates in a distinct sector, offering research, ratings, and insights that guide investment decisions for millions of individuals. While CME's core business lies in facilitating financial transactions, Morningstar's value proposition lies in its analysis and recommendations for investors.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
